mTOR inhibitor INK128 promotes wound healing by regulating MDSCs
Abstract Background Skin wounds in diabetic patients hardly recover. Accumulating evidence has shown that mammalian target of rapamycin (mTOR) pathway and myeloid-derived suppressor cells (MDSCs) are involved in inflammatory-related response. INK128 is a novel mTOR kinase inhibitor in clinical devel...
Main Authors: | Yi Li, Yujun Xu, Xinhan Liu, Xin Yan, Yue Lin, Qian Tan, Yayi Hou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-021-02206-y |
Similar Items
-
Correction to: mTOR inhibitor INK128 promotes wound healing by regulating MDSCs
by: Yi Li, et al.
Published: (2021-09-01) -
MDSCs participate in the pathogenesis of diffuse pulmonary hemorrhage in murine lupus through mTOR-FoxO1 signaling
by: Liping Tan, et al.
Published: (2022-12-01) -
Age-Related Alterations in Macrophage Distribution and Function Are Associated With Delayed Cutaneous Wound Healing
by: Christabel Thembela Dube, et al.
Published: (2022-07-01) -
Macrophage-Mediated Inflammation in Skin Wound Healing
by: Alireza Hassanshahi, et al.
Published: (2022-09-01) -
ALKBH5 regulates arginase 1 expression in MDSCs and their immunosuppressive activity in tumor-bearing host
by: Lili Feng, et al.
Published: (2024-09-01)